Angèle Schoenfelder

Title: Angèle Schoenfelder: Innovator in Hedgehog Protein Signaling Pathway Research

Introduction

Angèle Schoenfelder is a notable inventor based in Lampertheim, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the Hedgehog protein signaling pathway. With a total of 4 patents, his work has implications for various medical treatments.

Latest Patents

Schoenfelder's latest patents include innovative approaches to treating pathologies associated with tissue dysfunction due to deregulation of the Hedgehog protein signaling pathway. One of his key inventions involves the use of acylthiourea or acylurea derivatives for therapeutic purposes. This invention focuses on their application in treating conditions linked to the Hedgehog pathway, including tumors and neurodegenerative diseases. Another significant patent details compounds that modulate the Hedgehog protein signaling pathway, which can be used as drugs for various medical applications, including the treatment of diabetes and cerebrovascular accidents.

Career Highlights

Throughout his career, Angèle Schoenfelder has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the University of Strasbourg. His research has been pivotal in advancing our understanding of the Hedgehog signaling pathway and its role in various diseases.

Collaborations

Schoenfelder has collaborated with notable colleagues, including Martial Ruat and Hélène Faure. These partnerships have enriched his research and contributed to the development of innovative therapeutic strategies.

Conclusion

Angèle Schoenfelder's work exemplifies the intersection of innovation and medical research, particularly in the context of the Hedgehog protein signaling pathway. His contributions continue to influence the field and hold promise for future therapeutic advancements.